Carregant...
Price of a hepatitis C cure: Cost of production and current prices for direct-acting antivirals in 50 countries
OBJECTIVES: Seven years after the introduction of direct-acting antivirals (DAAs) for the treatment of hepatitis C, high prices remain a barrier for treatment programs worldwide. This study seeks to describe current prices for originator DAAs in 50 countries and evaluate the relationship between pri...
Guardat en:
| Publicat a: | J Virus Erad |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7646676/ https://ncbi.nlm.nih.gov/pubmed/33251019 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jve.2020.06.001 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|